A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study-Reference-Cited by-同舟云学术

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

Published:2018-09 Issue:9 Volume:19 Page:1180-1191
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Sun Roger,Limkin Elaine Johanna,Vakalopoulou Maria,Dercle Laurent,Champiat Stéphane,Han Shan Rong,Verlingue Loïc,Brandao David,Lancia Andrea,Ammari Samy,Hollebecque Antoine,Scoazec Jean-Yves,Marabelle Aurélien,Massard Christophe,Soria Jean-Charles,Robert Charlotte,Paragios Nikos,Deutsch Eric,Ferté Charles

Publisher

Elsevier BV

Subject

Oncology

Reference50 articles.

1. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology;Limkin;Ann Oncol,2017

2. The biology underlying molecular imaging in oncology: from genome to anatome and back again;Gillies;Clin Radiol,2010

3. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach;Aerts;Nat Commun,2014

4. In regard to Mattonen et al;Sun;Int J Radiat Oncol Biol Phys,2016

5. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

Cited by 875 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GHOST: Graph-based higher-order similarity transformation for classification;Pattern Recognition;2024-11

2. Deep learning to estimate response of concurrent chemoradiotherapy in non-small-cell lung carcinoma;2024-09-09

3. The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach;Frontiers in Immunology;2024-09-09

4. Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma;BMC Medicine;2024-09-02

5. Integrating radiomics and real-world data to predict immune-checkpoint inhibitors efficacy in advanced Non-Small Cell Lung Cancer;2024-09-02